| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |